REQUEST A QUOTE
CART(0)
Products for Quality Control
HOME
ABOUT US
PRODUCTS
Reference Standards
Drug Inhibitors
Drugs Intermediates
Isotope Compounds
By Category
By APIs Name
SERVICE
ORDER
NEWS
CONTACT US
Search
RELATED PRODUCTS
Home > Products > RELATED PRODUCTS
QCC CAT#
COMPOUND
ORDER
QC182600
Crizotinib
CAS# 877399-52-5;1415560-69-8(HCl salt)
M.F.: C21H22Cl2FN5O
M.W.: 450.34
Details
QC182601
Crizotinib Impurity 1
CAS# 877399-74-1
M.F.: C19H32BN3O4
M.W.: 377.29
Details
QC182602
Crizotinib Impurity 2
CAS# 877399-00-3
M.F.: C13H10BrCl2FN2O
M.W.: 380.04
Details
QC182603
Crizotinib Impurity 3
CAS# 1415558-82-5
M.F.: C21H20Cl2FN5O2
M.W.: 464.32
Details
QC182604
(S)-Crizotinib
CAS# 1374356-45-2
M.F.: C21H22Cl2FN5O
M.W.: 450.34
Details
QC182605
Crizotinib Impurity 5
CAS# NA
M.F.: C24H28Cl2FN5O
M.W.: 492.42
Details
QC182606
Crizotinib Impurity 6
CAS# NA
M.F.: C25H30Cl2FN5O2
M.W.: 522.45
Details
QC182607
Crizotinib-d5
CAS# NA
M.F.: C21H17D5Cl2FN5O
M.W.: 455.37
Details
QC182608
Crizotinib Impurity 8
CAS# 704-09-6
M.F.: C8H7Cl2FO
M.W.: 209.04
Details
QC182609
Crizotinib Impurity 9
CAS# 1448326-33-7
M.F.: C13H10BrCl2FN2O
M.W.: 380.04
Details
QC182610
Crizotinib Impurity 10
CAS# 1394346-24-7
M.F.: C13H8BrCl2FN2O3
M.W.: 410.02
Details
QC182611
Crizotinib Impurity 11
CAS# NA
M.F.: C13H10BrCl2FN2O
M.W.: 380.04
Details
QC182612
Crizotinib Impurity 12
CAS# NA
M.F.: C13H11Cl2FN2O2
M.W.: 317.14
Details
QC182613
Crizotinib Impurity 13
CAS# NA
M.F.: C26H40N6O4
M.W.: 500.64
Details
QC182614
Crizotinib Impurity 14
CAS# NA
M.F.: C21H22Cl2FN5O2
M.W.: 466.34
Details
QC182615
Crizotinib Impurity 15
CAS# 1675225-85-0
M.F.: C13H12Cl2N2O
M.W.: 283.15
Details
QC182616
Crizotinib Impurity 16
CAS# 2892666-62-3
M.F.: C26H41BN6O5
M.W.: 528.46
Details
QC182617
Crizotinib Impurity 17
CAS# NA
M.F.: C21H20Cl2FN5O3
M.W.: 480.32
Details
QC182618
Crizotinib Impurity 18
CAS# NA
M.F.: C13H17N5O
M.W.: 259.31
Details
×
Add to cart
Specifications
g
mg
Quantity
ADD
DISCLAIMER | PRIVACY POLICY | TERMS OF USE
© QUALITY CONTROL CHEMICALS INC. ALL RIGHTS RESERVED.